ArticleAdvanced healthcare materials2026
A Versatile Engineering Platform for the Fabrication of Prosthetic Venous Valves Using Electrospinning.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioinspired functional materials for biomedical applications.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Chronic venous insufficiency caused by valvular incompetence affects millions. Yet, functional prosthetic venous valves (PVVs) remain elusive. Previous concepts failed due to thrombosis and leaflet thickening caused by vascular cell hyperplastic overgrowth. Here, we address these issues by developing a fabrication platform for percutaneous PVVs by fully embedding the stent struts in electrospun fibers that extend luminally to form thin leaflets. This approach offers unique advantages: the electrospun matrix, with spatially controlled porosity, separates the leaflets from hyperproliferating vascular cells and the stent struts from the blood. Its continuity with the leaflets eliminates the need for anchoring points on the stent and associated fixation methods. As a result, stents of any type, cell design or length can be employed, with valve placement possible at any position. We demonstrate these benefits by fabricating bicuspid valves using segments of commercial stents and either single or multiple materials via dual electrospinning, such as thermoplastic polyurethane (TPU) lined with elastin-like recombinamers (ELRs). The ELR/TPU constructs exhibit minimal platelet adhesion, no hemolysis, and support endothelialization in vitro. Functional evaluation confirms excellent hydrodynamic performance. Finally, the platform's potential for other applications is shown with tricuspid small diameter pediatric heart valves successfully tested according to ISO 8540.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.